A Global Real World Evidence Study on the long-term effectiveness of ABBV-951 in Advanced Parkinson ́s Disease in routine clinical practice (ROSSINI: Real-world Outcomes with continuouS Subcutaneous levodopa INfusIon)

15965ABBVP22-487OpenA Global Real World Evidence Study on the long-term effectiveness of ABBV-951 in Advanced Parkinson ́s Disease in routine clinical practice (ROSSINI: Real-world Outcomes with continuouS Subcutaneous levodopa INfusIon)NCT06107426IndustrialAdultTreatmentIVOtherTorres-Yaghi, YasarGeorgetown University Medical Center : Michelle Umali; Lombardi Comprehensive Cancer Center : Michelle UmaliGUMC Neurology15434Michelle UmaliMichelle Umalimfu8@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>